Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Legemyrane 4 AS
AS
Active
Org 925669180
Legemyrane 4, 6076
Moltustranda
Rental and operating of own or leased real estate
·
NACE 6820
Est. 2020 · 5 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Rental and operating of own or leased real estate
/
Legemyrane 4 AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
5M
4M
2M
1M
0M
2021: 1M
1M
2021
2022: 3M (+200% vs 2021)
3M
+200%
2022
2023: 1M (-67% vs 2022)
1M
-67%
2023
2024: 4M (+300% vs 2023)
4M
+300%
2024
EBITDA
NOK millions
3M
2M
0M
-1M
-2M
2021: -1M
-1M
2021
2022: 1M (+200% vs 2021)
1M
+200%
2022
2023: 0M (-100% vs 2022)
0M
-100%
2023
2024: 2M
2M
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
Revenue
4 407
1 160
2 593
1 200
Staff expenses
−0
−0
−0
−0
EBITDA
2 323
372
961
−909
Depreciation & amort.
−322
−234
−222
−163
EBIT
2 001
139
739
−1 071
Net financials
−1 723
−2 365
−1 905
−582
Profit before tax
278
−2 226
−1 166
−1 653
Tax
−9
−0
308
−364
Net profit
287
−2 235
−1 474
−1 289
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
Total assets
10 710
11 695
6 673
7 709
Equity
−4 489
−4 776
−2 541
−1 067
Long-term debt
13 911
12 022
8 408
8 129
Short-term debt
1 289
4 449
805
647
Total debt
15 199
16 471
9 214
8 777
Financial ratios
5-year trend
EBITDA margin
52,7 %
This company
15,8 %
Market median
This company
Market median
234% above market
2021
2024
Equity ratio
−41,9 %
This company
38,2 %
Market median
This company
Market median
210% below market
2021
2024
Return on equity
—
This company
18,4 %
Market median
This company
Market median
2021
2024
Net profit margin
6,5 %
This company
8,1 %
Market median
This company
Market median
20% below market
2021
2024
Asset turnover
0,41×
This company
1,12×
Market median
This company
Market median
63% below market
2021
2024
Debt / equity
—
This company
0,62×
Market median
This company
Market median
2021
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Legemyrane 4 AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
